Cargando…
Guillain–Barré syndrome following coronavirus disease vaccine: First report from Nepal
ChAdOx1 nCoV-19 is an effective and well-tolerated coronavirus disease 2019 vaccine. However, rare cases of serious adverse events have been reported with it. We report a patient who did not have active or prior coronavirus disease 2019 infection, who developed Guillain–Barré syndrome 7 days followi...
Autores principales: | Luitel, Prajjwol, Poudel, Bibek, Upadhyay, Devansh, Paudel, Sujan, Tiwari, Nishan, Gajurel, Bikram Prasad, Karn, Ragesh, Rajbhandari, Reema, Shrestha, Aashish, Gautam, Niraj, Ojha, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130842/ https://www.ncbi.nlm.nih.gov/pubmed/35646371 http://dx.doi.org/10.1177/2050313X221100876 |
Ejemplares similares
-
Guillain–Barre Syndrome following lower segment caesarean section under spinal anesthesia: A case report
por: Luitel, Prajjwol, et al.
Publicado: (2022) -
Paraparetic Guillain‐Barre syndrome: An uncommon diagnosis of acute flaccid paralysis of the lower limbs
por: Luitel, Prajjwol, et al.
Publicado: (2021) -
Guillain‐Barré syndrome associated with Coronavirus disease 2019: A case from Nepal
por: Aryal, Roshan, et al.
Publicado: (2022) -
Isolated extrapontine myelinolysis with neuropsychiatric manifestation: A
case report from Nepal
por: Karki, Susmin, et al.
Publicado: (2021) -
Recurrent Bilateral Optic Neuritis Associated with Myelin Oligodendrocyte Glycoprotein Antibody: A Case Report from Nepal
por: Shah, Sangam, et al.
Publicado: (2021)